B r i e f c o m m u n i c at i o n s
The mammalian cerebral cortex contains an unparalleled diversity of neuron types. Glutamatergic projection neurons represent the majority of cortical neurons, and they include many subtypes, each with distinct anatomical and functional properties 1 . Corticofugal (CFu) projection neurons are one subpopulation of cortical projection neurons that reside in deep layers Vb and VI of the cortex. They connect the cortex to its subcortical and subcerebral targets in the thalamus, brainstem and spinal cord 1 . The generation of CFu neurons in the embryo is a multistep process that begins with the fate specification of neural progenitors to acquire cortical (dorsal) identity at the expense of ventral progenitor identity. Among other genes, this requires expression of Pax6 and Emx2 (refs. 2,3) . In addition, cortical progenitors are specified to a glutamatergic fate, which is dependent on the expression of Pax6, Ngn1 and Ngn2 (ref. 4) . Finally, the differentiation of individual populations of projection neurons is controlled by neuronal subtypespecific genes, which have only begun to be identified. By comparing expression profiles of pure populations of corticospinal motor neurons (CSMN) and callosal projection neurons (CPN), we previously identified genes that define these projection neuron subtypes 5, 6 . Among these, the transcription factor Fezf2 is necessary for the specification of CSMN and related populations of subcerebral projection neurons, and it is sufficient to specify CFu projection neurons during late corticogenesis [7] [8] [9] . This suggests that Fezf2 alone might be able to instruct projection neuron subtype-specific development from neural progenitors of a different cell fate, within neurogenic niches of other CNS regions.
Here, we investigated whether the ectopic expression of Fezf2 in neural progenitors of the striatum would be sufficient to instruct the generation of CFu projection neurons, bypassing typical requirements for early cortical progenitor patterning and glutamatergic specification. We injected a Fezf2 GFP expression vector (Fezf2 combined with an internal ribosomal entry site (IRES) and GFP) in the lateral ventricle under ultrasound guidance at embryonic day (E) 12.5 and directionally electroporated it in utero into neural progenitors of the lateral ganglionic eminence (LGE). Electroporated embryos were allowed to develop until E18.5. LGE progenitors normally give rise to GABAergic medium spiny neurons (MSN) of the striatum and interneurons of the olfactory bulb 10 . They do not produce cortical projection neurons. In situ hybridization for Fezf2 showed that it is not normally expressed within the LGE and in other regions of the developing and postnatal striatum ( Supplementary Fig. 1 and ref. 9 ). We found that Fezf2 GFP -electroporated LGE progenitors gave rise to neuronal progeny that migrated within the developing striatum, similarly to non-electroporated MSN (Fig. 1) . However, despite being located within the niche of the striatum, Fezf2 GFP -neurons expressed proteins that are specific to CFu neurons of the cerebral cortex. These included SOX5, typically expressed in all CFu neurons; TBR1, a gene expressed at high levels In the developing cerebral cortex, cell-extrinsic and cellintrinsic signals govern the establishment of neuron subtypespecific identity. Here we show that, within the niche of the striatum, the expression of a single transcription factor, Fezf2, is sufficient to generate corticofugal neurons from progenitors fated to become medium spiny neurons. This demonstrates that a specific population of cortical projection neurons can be directed to differentiate outside of the cortex by cellautonomous signaling. Figure 1 LGE progenitors generate neurons with corticofugal molecular properties in response to Fezf2. Fezf2 GFP -expressing neurons located in the striatum express SOX5, TBR1, BHLHB5 and ZFPM2 (arrows), which are absent from the contralateral striatum (arrowheads). Ctx, cortex; LV, lateral ventricle; Str, striatum; CC, corpus callosum. Scale bars, 500 μm.
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VOLUME 13 | NUMBER 11 | NOVEMBER 2010 nature neuroscience B r i e f c o m m u n i c at i o n s in layer VI, in a subset of layer V CFu neurons and at lower levels in upper layer cortical neurons; BHLHB5 (BHLHE22), a transcription factor that early in development labels subcerebral projection neurons, including CSMN; and ZFPM2 (FOG2), normally expressed in layer VI cortical neurons (n = 4) (see Supplementary Methods for primary references). In contrast, none of these proteins were expressed in MSN developing in the unelectroporated contralateral hemisphere (Fig. 1) . Quantification of the percentage of Fezf2 GFP -electroporated neurons expressing CFu neuron markers showed that 82.8 ± 3.1% expressed TBR1 (n = 4) and 41.1 ± 5.2% expressed BHLHB5 (n = 2), a gene that at this age can distinguish subcerebral projection neurons of layer Vb from CFu neurons of layer VI. The data support a model by which, among the CFu neuron classes, Fezf2 instructs the birth of both subcortical projection neurons of layer VI and subcerebral projection neurons of layer V. Fezf2 GFP -electroporated neurons were also positive for Vglut1, which they expressed at levels comparable to those in neocortical projection neurons at this age, indicating that they had acquired a glutamatergic identity (Supplementary Fig. 2) . To determine whether, in addition to molecular properties of CFu neurons, Fezf2 GFP -electroporated neurons developed aspects of neuronal pyramidal morphology typical of cortical projection neurons, we let mice electroporated with either Fezf2 GFP or control GFP develop until postnatal day 15 and analyzed neuronal morphology (Supplementary Fig. 3a) . We found that 63.8 ± 0.9% of Fezf2 GFP neurons showed pyramidal-like morphology with a distinct primary process that resembled an apical dendrite (n = 4) ( Supplementary  Fig. 3b,c) . This corresponded to three times as many pyramidal-like neurons as in control GFP-electroporated brains, and it was accompanied by a reduction in the number of neurons with stellate-like morphology (typical of MSN) to one-third of that in the control (Supplementary Fig. 3b,c) . The data indicate that a distinct fraction of the Fezf2 GFP neurons can cell-autonomously acquire morphological features of cortical projection neurons. These results motivated us to investigate long-distance axonal connectivity by the electroporated neurons. Not surprisingly, given their ectopic location, many Fezf2 GFP neurons projected to the substantia nigra, however, by postnatal day 15, we observed extensive innervation of the thalamus and the cerebral peduncle ( Supplementary Fig. 4a-e) . Considering the central role of the environment in axon guidance and target innervation, it is noteworthy that several of the Fezf2 GFP -positive neurons (albeit not all of them) were able to reach targets that are appropriate for layer VI (namely, thalamus) and V (namely, cerebral peduncle) CFu projection neurons.
To determine whether, in response to ectopic Fezf2 expression, LGE progenitors undergo a full change of fate or, rather, give rise to neurons of mixed lineage identity, we performed in situ hybridization on electroporated brains for Meis2, Islet1 and Drd2, three genes that label the majority of MSN and are absent from the cerebral cortex ( Fig. 2a; see 
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Supplementary Methods for primary references). Examination of the striatum in the Fezf2 GFP -electroporated hemisphere revealed distinct areas that were depleted of Meis2, Islet1 and Drd2 expression (Fig. 2a) . We found that TBR1-positive CFu projection neurons occupied these spaces, exactly bordering and not overlapping with neighboring MSN (Fig. 2a) . The absence of Drd2 expression suggests that these neurons may not be able to respond to dopaminergic nigrostriatal input. In addition, and in contrast to GABAergic MSN, Fezf2 GFP -expressing neurons did not express GAD67, an enzyme necessary for GABA synthesis (Fig. 2b) (Fig. 3a) or PAX6 (Fig. 3b) . In addition, they did not express TBR2, a marker of cortical intermediate progenitors (Fig. 3c) . On the contrary, they maintained expression of GSH2 and Mash1 ( Supplementary Fig. 5a,b) . Finally, a time course of analysis for TBR1 expression showed that this postmitotic cortical marker appeared as early as 2 d (3 ± 1.5% of neurons; n = 2) and 4 d (16 ± 2.3% of neurons; n = 2) after electroporation, with 82.8 ± 3.1% of neurons expressing TBR1 at E18.5 (n = 4). These results indicate that LGE progenitors did not need to adopt cortical progenitor identity to generate CFu projection neurons in response to Fezf2, and support the possibility that Fezf2 may act postmitotically.
Together, the data demonstrate that a single transcription factor, Fezf2, is sufficient to instruct progenitors of GABAergic MSN to switch fate and generate a specific population of glutamatergic projection neurons of the cerebral cortex: corticofugal projection neurons. This effect is independent from the expression by LGE progenitors of Pax6 and Ngn2, which in the cortex are centrally important for the generation of glutamatergic projection neurons 4 . Ngn2 in particular was also recently found to be sufficient to ectopically instruct glutamatergic identity 11 . A large number of neurons acquired molecular features of CFu neurons, and a subpopulation also developed pyramidal-like morphology and connectivity to CFu-appropriate subcortical and subcerebral targets. This switch of fate occurred despite the location of the newly generated CFu neurons within the striatum, a niche that does not normally host development of cortical projection neurons. Of note, despite this ectopic location, these neurons survived and could mature in the postnatal striatum. Previous transplantation experiments have shown that basal ganglia progenitors retain the ability to generate different types of neurons if removed from their own niche and exposed to extracellular signals of other neurogenic regions [12] [13] [14] . Our experiments now demonstrate that cell-autonomous signals that drive neuron type-specific development in the cortex can override extracellular niche restrictions and instructions as to progenitor cell fate. These findings support a model in which key transcription factors might be used to direct the differentiation of clinically relevant neuron types for future therapeutic benefit.
Note: Supplementary information is available on the Nature Neuroscience website.
